The GLP-1 Revolution: Analyzing the Benefits and Impact on Healthcare in GermanyGermany is presently at the forefront of a substantial shift in metabolic medication. As the most populated nation in the European Union, Germany faces rising rates of obesity and Type 2 diabetes-- conditions that position a significant concern on
